Novo Nordisk $NVO vs Eli Lilly $LLY: Valuation Gap Signals...
Key Takeaways Valuation Discrepancy: As of mid-2025, Eli Lilly’s market capitalisation of approximately $850 billion is more than double that of Novo Nordisk’s $330 billion, despite both companies dominating the...